Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...
The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide ...
Novo said supply of Wegovy and Ozempic is in good shape after the drugs were removed from the FDA’s shortage list last week.
Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) were down 0.7% during mid-day trading on Friday after Barclays lowered their price target on the stock from $1,025.00 to $975.00. Barclays ...
US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...
Discover the top 10 biggest companies in the world in 2024, featuring industry giants leading the global economy.
Ladies and gentlemen, thank you for standing-by, and welcome to the Lilly Q3 2024 Earnings Call. [Operator Instructions] I ...
Here's why Eli Lilly is a no ... Even Lilly's insulin product Humalog, which was first approved by the U.S. Food and Drug ...
Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...
Hunter Associates Investment Management LLC trimmed its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 0.8% in ...
Revenue in Q3 2024 increased 20%, driven by volume growth from Mounjaro and Zepbound, partially offset by $1.42 billion of revenue in Q3 2023 from the sale of rights for the olanzapine portfolio ...